Femoropopliteal bypass
Femoropopliteal Bypass
A femoropopliteal bypass is a surgical procedure performed to create a new pathway for blood flow in the lower extremities. This procedure is commonly used to treat peripheral arterial disease (PAD) when the femoral artery or popliteal artery becomes blocked or narrowed, restricting blood flow to the lower leg and foot.
Procedure[edit | edit source]
During a femoropopliteal bypass, a vascular surgeon creates a bypass graft using a synthetic tube or a vein harvested from the patient's own body. The graft is then attached above and below the blocked or narrowed segment of the artery, allowing blood to flow through the new pathway and bypass the obstruction.
The surgery is typically performed under general anesthesia, and the patient may need to stay in the hospital for a few days for monitoring and recovery. After the procedure, patients are advised to follow a healthy lifestyle, including regular exercise and a balanced diet, to prevent further progression of PAD.
Risks and Complications[edit | edit source]
As with any surgical procedure, femoropopliteal bypass surgery carries certain risks and potential complications. These may include infection, bleeding, blood clots, graft failure, and nerve damage. Patients should discuss the risks and benefits of the procedure with their healthcare provider before undergoing surgery.
Recovery and Prognosis[edit | edit source]
Recovery from femoropopliteal bypass surgery varies from patient to patient but generally involves a period of rest and rehabilitation. Most patients experience improved blood flow to the lower extremities following the procedure, which can help alleviate symptoms such as pain, cramping, and numbness.
The long-term prognosis for patients who undergo femoropopliteal bypass surgery is generally good, especially when combined with lifestyle modifications and ongoing medical management of PAD risk factors.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
